Sonoma Pharmaceuticals, Inc. (SNOA) Amy Trombly, CEO

The Wall Street Resource

İçerik Wall Street Resource, LLC, Wall Street Resource, and LLC tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Wall Street Resource, LLC, Wall Street Resource, and LLC veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

1+ y ago 27:04

Sonoma Pharmaceuticals

is a global healthcare leader for developing and producing stabilized

hypochlorous acid (HOCl) products for a wide range of applications, including

wound care, eye care, nasal care, oral care, dermatological conditions, animal

health care and non-toxic disinfectants. The company's products reduce

infections, itch, pain, scarring and harmful inflammatory responses in a safe

and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl)

show it to have impressive antipruritic, antimicrobial, antiviral and

anti-inflammatory properties. Sonoma's stabilized HOCl immediately relieves

itch and pain, kills pathogens and breaks down biofilm, does not sting or

irritate skin, and oxygenates the cells in the area treated, assisting the body

in its natural healing process. The company's products are sold either directly

or via partners in 55 countries worldwide.

154 bölüm

published 1+ y ago

Paylaş